{"DataElement":{"publicId":"5485881","version":"1","preferredName":"Clinical Course of Disease Assessment European Treatment Outcome Study Score Value","preferredDefinition":"The European Treatment Outcome Study Score value measured, assigned or computed related to the clinical course of disease assessment.","longName":"5599527v1.0:5485872v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5599527","version":"1","preferredName":"Clinical Course of Disease Assessment","preferredDefinition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.)._The final result of a determination of the value, significance, or extent of.","longName":"5599525v1.0:2465182v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5599525","version":"1","preferredName":"Clinical Course of Disease","preferredDefinition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.).","longName":"C35461","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Course of Disease","conceptCode":"C35461","definition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43401C15-1331-7CB8-E053-F662850AF829","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43401C15-133F-7CB8-E053-F662850AF829","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"NYCHM","dateModified":"2017-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5485872","version":"1","preferredName":"European Treatment Outcome Study Score Value","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis._A numerical quantity measured or assigned or computed.","longName":"5485872v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5599528","version":"1","preferredName":"European Treatment Outcome Study Score Value","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.:A numerical quantity measured or assigned or computed.","longName":"C127872:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Treatment Outcome Study Score","conceptCode":"C127872","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"433FF181-0047-588A-E053-F662850A224A","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7E4A90-B36C-7EC6-E053-F662850AA2A9","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLP_DADX_EUTOS_score_value","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the European Treatme","type":"Preferred Question Text","description":"What was the European Treatment Outcome Study Score value related to the clinical course of disease assessment?","url":null,"context":"NHLBI"},{"name":"Specify the EUTOS score:","type":"Alternate Question Text","description":"Specify the EUTOS score:","url":null,"context":"NHLBI"},{"name":"Specify the EUTOS score:","type":"Application Standard Question Text","description":"Specify the EUTOS score:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7E7810-4B01-59CF-E053-F662850A6BAB","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}